Reid Huber, EVP, Chief Scientific Officer at Incyte, holds 20.40K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 5.00K shares in Tango Therapeutics (Ticker: TNGX), holds 34.57K shares in Incyte (Ticker: INCY). Most recently, Reid Huber Bought ― shares of Rapport Therapeutics, Inc. on Sep 15, 2025 for an estimated value of $499.19K.
Reid Huber latest transaction was an Informative Buy of $499.19K.
What was Reid Huber's most profitable transaction?
Reid Huber’s most profitable transaction was an Informative Buy of INCY stock on November 14, 2014. The return on the trade was 54.30%.
What is Reid Huber's role in Incyte?
Reid Huber's role in Incyte is EVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.